BIOCRYST PHARMACEUTICALS INC (BCRX) Institutional Ownership and Insiders Activity
BIOCRYST PHARMACEUTICALS INC (BCRX) is widely held by institutional investors, with 306 firms reporting positions valued at approximately $2.58B based on SEC Form 13F filings for the quarter ended June 30, 2026.
Blackrock, Inc. is the largest disclosed holder, reporting approximately $238.93M in BCRX holdings in its latest filing.
Recent insider activity includes 5 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.
Institutional Holders
306
Total Reported Value
$2.58B
Largest Holder
Blackrock, Inc.
Largest Position
$238.93M
Insider Transactions (90d)
5
Latest Filing Quarter
Q2 2026
New Institutional Positions
55
Funds Exiting Positions
44
Top Institutional Owners
View allInvestorReported Balance
- Blackrock, Inc.$238.93M
- Ra Capital Management, L.P.$158.27M
- State Street Corp$151.91M
- Deerfield Management Company, L.P.$150.96M
- Vanguard Capital Management Llc$113.64M
Related BCRX Institutional Insights:
- BCRX 13F Institutional Holders
- BCRX Top Institutional Shareholders
- BCRX Institutional Ownership Changes
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- BCRX Insider Trading & SEC Form 4 Activity
- BCRX Articles
- Top Institutional Investor Stock Rankings